Fatima Adnan Alzubaidi

Fatima Adnan Alzubaidi

Auto-generated profile, based on publicly available information

Fatima Adnan Alzubaidi

Department of Pharmacology and Toxicology, College of Pharmacy, University of Babylon, Babylon, Iraq

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2024 in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
Verified
Journal Article
Closed access
IOIsmael Obaidi
Ismael Obaidi
FAFatimah Adnan Alzubaidi
Fatimah Adnan Alzubaidi
ABAymen A. Bash
Aymen A. Bash
QFQayssar Joudah Fadheel
Qayssar Joudah Fadheel
HAHussam Al-Humadi
Hussam Al-Humadi
JLJunying Liu
Junying Liu
Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for 90% of all estimated cases. Advanced RCC often carries poor prognosis due to its high metastases rate, the lack of early-warning signs, as well as its complex clinical manifestations and its resistance to chemotherapy. Ethnopharmacologically, Fructus Rosae laevigata (JinYingZi) has been employed by Chinese medicine to treat various urinary tract and gastrointestinal dis¬orders. This study aimed at performing a series of mechanistic analyses in order to unlock the anticancer potential of JinYingZi-derived bioactive components against RCC. Several network pharmacology tools were employed so as to analyse the drug-disease interactions. Our data revealed that more than 2,214 genes were dysregulated in RCC, whereas the JinYingZi-derived bioactive compounds modulated 347 genes. The intersecting between RCC and the bioactive compounds revealed 132 cross targets. Our results were further validated by conducting molecular docking, which revealed a stable association between oleanolic acid with each of the following targets: androgen receptor (AR), dipeptidyl peptidase (DPP), estradiol (ESR1), nitric oxide synthase 2 (NOS2), and cyclooxygenase-2 (PTGS2). Our approach is being used successfully in order to evaluate a panel of novel medicinal plant-derived bioactive com¬pounds, and may lead to the identification of safe and effective chemical scaffolds that could act as templates for drug discovery or yield potential drug candidates.

11 June 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MMMohammed Mahdi-Abdulamir
Mohammed Mahdi-Abdulamir
SMSomayeh Karami Mohajeri
Somayeh Karami Mohajeri
MSMansoureh Sabzalizadeh
Mansoureh Sabzalizadeh
FAFatima Adnan Alzubaidi
Fatima Adnan Alzubaidi
FAFatemeh Abedi
Fatemeh Abedi
BackgroundValproic acid (VPA) is an important antiepileptic medication, but its continuous use is limited by serious neurotoxic side effects, including cognitive impairment and neuronal cell death. In this study, we examined how co-administering VPA with melatonin (MEL) and vitamin B6 could help control seizures while avoiding an increase in VPA-related neurotoxicity, using PTZ-induced seizures as a model.MethodsMale Wistar mice were assigned at random to five groups (n=8 in each group): control animals receiving saline, animals treated with VPA at 250 mg/kg, animals treated with VPA at 500 mg/kg, animals given VPA 250 mg/kg combined with MEL (10 mg/kg) and B6 (50 mg/kg), and animals given VPA 500 mg/kg combined with MEL and B6. Injections were given intraperitoneally once daily for 14 days. After treatment, seizures were triggered with PTZ at 35 mg/kg. Seizure outcomes, including latency, overall duration, and severity, were determined using the Modified Racine Scale. Behavioral performance was evaluated with Novel Object Recognition (NOR), Novel Texture Recognition (NTR), shuttle box avoidance, and the Elevated Plus Maze (EPM). Finally, histopathological alterations in the hippocampus were assessed using Nissl staining.ResultsThe combination therapy (VPA 500 mix) markedly increased seizure onset latency (70.0 ± 0.0 s vs. 44.7 ± 4.9 s in controls, p<0.01) and shortened seizure duration (586.0 ± 57.8 s vs. 961.2 ± 114.7 s, p<0.01) compared with the control group. All groups treated with VPA completely eliminated stage 6 seizures. The VPA 500 mix group also showed better cognitive outcomes, with a 192% rise in the NOR discrimination index and a 183% increase in the shuttle box avoidance index compared to controls (p<0.01). On histopathological analysis, VPA 500 mix preserved 71% of intact neurons and brought the degenerated cell ratio back toward normal when compared with VPA 500 monotherapy (p<0.001). Anxiolytic effects were evident as well, indicated by increased time spent in the open arms of the EPM, while locomotor activity remained unchanged.ConclusionCoadministration of VPA with melatonin and vitamin B6 produces synergistic effects, significantly improving seizure control, preserving cognitive function, and providing robust neuroprotection. This triple combination represents a promising adjunctive strategy to overcome VPA-induced neurotoxicity in epilepsy management.

1 January 2026 in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Verified
Journal Article
Open access
PDF file
EOEnass Najem Oubaid
Enass Najem Oubaid
NHNoor Ali Hussein
Noor Ali Hussein
GNGhada Hamid Naji
Ghada Hamid Naji
FAFatima Adnan Alzubaidi
Fatima Adnan Alzubaidi
Background: Ulcerative colitis is a persistent mucosal inflammation of the bowel that impacts a high portion of the population worldwide. It often presents with symptoms of severe diarrhea, weight reduction, and perianal bleeding. Objective: To investigate the potential anti-inflammatory effects of azilsartan on dextran sulfate-induced ulcerative colitis in rats. Methods: Forty healthy adult albino rats were divided into 4 groups, as follows: the normal control group, the DSS group, DSS+ prednisolone (10 mg/kg/day) group, and DSS+azilsartan (10 mg/kg/day) group. The colitis induction was prompted in rats by administering 3% DSS in drinking water for 7 days. Results: The administration of azilsartan notably decreased edema index, spleen index, macroscopic changes scores, and microscopic changes scores that were produced by DSS. Additionally, azilsartan markedly reduced the proinflammatory cytokine expression, including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in colon tissue. Furthermore, azilsartan significantly attenuated oxidative stress in colonic tissue by decreasing up-regulated myeloperoxidase (MPO) enzyme activity and increasing down-regulated catalase antioxidant activity. Conclusions: Azilsartan may have an effective role in the treatment of ulcerative colitis.

5 May 2024 in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
Verified
Journal Article
Closed access
FAFatima Adnan Alzubaidi
Fatima Adnan Alzubaidi
EOEnass Najem Oubaid
Enass Najem Oubaid
ZSZahraa I. J. Shubber
Zahraa I. J. Shubber
HAHussam Al-Humadi
Hussam Al-Humadi
RARafal J. Al-Saigh
Rafal J. Al-Saigh
Reinfection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has been documented all over the world. Currently, limited evidence exists concerning the protec¬tion afforded by the COVID-19 vaccination against reinfection with SARS-CoV-2. This case-control study was per¬formed in order to assess the association between COVID-19 vaccination and SARS-CoV-2 reinfection in the Babil Province; the study used an electronic questionnaire. The infected patients were 115 (aged ≥18 years) and were confirmed by a positive PCR and/or a CT scan, they were either fully vaccinated or not with a second dose of a (Pfizer, AstraZeneca, or Sinopharm) vaccine before the reinfection date, and they were compared with 300 control partici¬pants. The study’s findings revealed that the unvaccinated individuals had 4.5 times the odds of reinfection compared to those who were fully vaccinated, without preference for the manufacturer of the vaccine. The conclusion suggests that getting fully vaccinated against COVID-19 can significantly reduce the likelihood of reinfection, can enhance overall protection, and can minimize the risk of future infections.